Altamira Therapeutics Ltd. Form 8-K12G3: 8-K12G3
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2019-03-18: Form 8-K12G3; Period of report 2019-03-18; Description FORM 8-K12G3; Document dp103770_8k12g3.htm.
- 2018-03-20: Form 8-K12G3; Period of report 2018-03-12; Description FORM 8-K12G3; Document dp88364_8k12g3.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2019-03-18 | 8-K12G3 | 2019-03-18 | FORM 8-K12G3 | dp103770_8k12g3.htm |
| 2018-03-20 | 8-K12G3 | 2018-03-12 | FORM 8-K12G3 | dp88364_8k12g3.htm |